Results 11 to 20 of about 8,261 (192)

Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers

Human Vaccines & Immunotherapeutics, 2023
The evidence on the waning protection of COVID-19 vaccines has been reviewed by the World Health Organization and has led to consideration of the need for booster doses.
Hazal Cansu Çulpan, Sümeyye Nur Aydın, Abdulkerim Uygur, Uğurcan Sayılı, Erkam Şeker, İ̇lker İnanç Balkan, Rıdvan Karaali, Beyhan Budak, Yılmaz Keskindemirci, Neşe Saltoğlu, Günay Can   +10 more
doaj   +5 more sources

Antibody dynamics post-Comirnaty and CoronaVac vaccination in Malaysia

Scientific Reports, 2022
Several vaccines have been fast-tracked through clinical trials to mitigate the progression of the SARS‑CoV‑2 pandemic. We analyzed sequential blood samples from 314 recipients of Comirnaty and CoronaVac in East Malaysia for the spike-binding IgG (IgG-S),
Cheng Siang Tan, Vaenessa Noni, Whilemena Upam Herman Ulok Melina, Ummi Syafiqah Abdorahman, Joseph Niler Bimbang, Natasya Marliana Abdul Malik, Mohammad Esa Hossen, Md Mizanur Rahman, Lela Su’ut, Asri Said, Claire Chen, Bego Sepop, Morni Abu Samat, John Chee Ming Chew, Dewi Mamora, Sian Kong Tan   +15 more
doaj   +5 more sources

CoronaVac vaccine does not affect ovarian reserve [PDF]

Ginekologia Polska, 2023
Objectives: In this study, our aim is to investigate the effect of CoronaVac vaccine on ovarian reserve in female patients followed up for infertility.Material and methods: Our study is a retrospective study. Forty-six infertile patients who received two
Senkaya, Ayse Rabia, Keskin, Omur, Gunes, Mehmet Emin, Ömür Keskin, Zafer Çil, Mehmet Emin Güneş, Deniz Can Öztekin, Cil, Zafer, Oztekin, Deniz Can, Ayşe Rabia Şenkaya   +9 more
core   +4 more sources

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil [PDF]

Nature Medicine, 2022
There is considerable interest in the waning of effectiveness of coronavirus disease 2019 (COVID-19) vaccines and vaccine effectiveness (VE) of booster doses.
Katikireddi, Srinivasa Vittal, Pearce, Neil, Júnior, Juracy Bertoldo, Paixão, Enny S, Boaventura, Viviane S, Penna, Gerson O, Barral-Netto, Manoel, Cerqueira-Silva, Thiago, de Araujo Oliveira, Vinicius, Robertson, Chris, Werneck, Guilherme L, Barreto, Maurício L., Flores-Ortiz, Renzo, Sheikh, Aziz   +13 more
core   +13 more sources

Immunogenicity after CoronaVac vaccination [PDF]

Revista da Associação Médica Brasileira, 2021
OBJECTIVE: This study aimed to investigate the seropositivity of CoronaVac-SinoVac vaccination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) risk factors and comorbidities.
Güzel, Eda Çelik, Çelikkol, Aliye, Sedef, N., Erdal, Berna   +3 more
core   +7 more sources

Humoral Immune Response of BNT162b2 and CoronaVac Vaccinations in Hemodialysis Patients: A Multicenter Prospective Cohort [PDF]

Vaccines, 2022
The CoronaVac vaccine is the most used anti-SARS-CoV-2 vaccine worldwide. Previous data indicate that this vaccine produces a lower immune response than RNA vaccines such as BNT162b2.
Rene Clavero, Alfredo Parra-Lucares, Gabriel Méndez-Valdés, Eduardo Villa, Karin Bravo, Evelyn Mondaca, Josseline Aranda, Rose Brignardello, Cynthia Gajardo, Angelica Ordenes, Evelyn Colombo, Jessica Tapia, Andoni Etcheverry, José Zúñiga, Luis Toro   +14 more
doaj   +2 more sources

Immunogenicity and Reactogenicity of CoronaVac: A Cohort Study

COVID, 2022
The ongoing COVID-19 pandemic remained a major public health concern despite a large-scale deployment of vaccines. One of the vaccines is CoronaVac, an inactivated vaccine. The efficacy of the vaccine was estimated at 50.7–83.5% in clinical trials.
Nyoman Ratna Kartika Dewi, I Gde Raka Widiana, Sri Masyeni, Anak Agung Gede Budhitresna, Edison Johar, Khin Saw Aye Myint, Frilasita Aisyah Yudhaputri, Nyoman Mahardika   +7 more
core   +2 more sources

Correlation Between Knowledge Level On Anxiety Level Post-Coronavac Vaccine at The Clinic of dr. Irma

Saintika Medika, 2021
Vaccination is the government's effort to prevent the spread of the COVID-19 pandemic. Lack of knowledge about the Coronavac vaccine gives rise to various kinds of speculation, resulting in anxiety. This study attempts to analyze evaluate the correlation
Marintik Ilahi, Yusrin Aulia
doaj   +3 more sources

Sobre a eficácia da CoronaVac no Twitter: conversações e aspectos políticos

Liinc em Revista, 2022
A CoronaVac, desenvolvida no Brasil pelo Instituto Butantan em parceria com a Sinovac, manteve-se em meio às disputas políticas que permearam o modo como o nosso país enfrentou a pandemia da COVID-19. Com o objetivo de mapear e compreender, em um período
Carina Luisa Ochi Flexor, Gustavo Costa, Vitória Lobo Batista Barros   +2 more
doaj   +2 more sources

Humoral Immune Response to CoronaVac in Turkish Adults

Vaccines, 2023
While most approved vaccines are based on the viral spike protein or its immunogenic regions, inactivated whole-virion vaccines (e.g., CoronaVac) contain additional antigens that may enhance protection.
Katja Steinhagen, Korukluoglu, Gulay, Evelin Grage-Griebenow, Grage-Griebenow, Evelin, Susann Hohensee, Saschenbrecker, Sandra, Kamiloglu, Ayten Öz, Gulay Korukluoglu, Steinhagen, Katja, Hohensee, Susann, Yasemin Cosgun, Ayten Öz Kamiloglu, Emanet, Nergis, Cosgun, Yasemin, Sandra Saschenbrecker, Nergis Emanet   +15 more
core   +5 more sources